Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...

Mounjaro explained as 'All About That Bass' singer Meghan Trainor admits to using it amid major weight loss transformation.

The line-up consists of supplements to meet the health needs to patients taking GLP-1 medications for weight loss.

Meghan Trainor has revealed she has Mounjaro to thank for her new look alongside diet and exercise but she's not the only one ...

Wockhardt will deepen its novel antibiotics pipeline over the next five years and focus on building a biosimilar business for ...

Jeremy Clarkson was the latest name in a long line of celebs that have tried their hand at Ozempic. The British TV presenter ...

More than 40 products have been deemed adulterated and unsafe for the UAE market since January by the Abu Dhabi health ...

New York’s reputation as a trailblazer for health equity is in danger. We must ensure equity in obesity treatment.

KKR has abandoned a private equity consortium discussing a takeover of Gerresheimer AG , Bloomberg News reported on Thursday, ...

With two new lawsuits, Eli Lilly (NYSE: LLY) has escalated its legal campaign against the makers of unauthorized versions of ...

Ozempic is a prescription GLP-1 drug for weight loss, while yerba mate is a natural tea that boosts metabolism and curbs ...